#United States #New York #Pomerantz #SelectQuote #DOJ Complaint

Investor Alert: Pomerantz Law Firm Investigates SelectQuote, Inc.

Pomerantz LLP, a renowned law firm specializing in corporate and securities litigation, is currently conducting an investigation into claims on behalf of investors of SelectQuote, Inc. (NYSE: SLQT). This scrutiny comes on the heels of serious allegations raised in a recent complaint by the U.S. Department of Justice (DOJ), which targets several insurance companies, including SelectQuote.

On May 1, 2025, the DOJ filed a lawsuit under the False Claims Act, accusing SelectQuote and other named organizations of participating in a scheme that included paying illegal kickbacks to brokers in exchange for enrollments into Medicare Advantage plans. The allegations suggest that these activities occurred over a significant period—from 2016 to 2021—and involved hundreds of millions of dollars in improper payments. This could potentially lead to significant liabilities for SelectQuote and its stakeholders.

Following the announcement of the DOJ's legal action, SelectQuote's stock experienced a sharp decline, plummeting $0.61 per share, which translates to a 19.24% drop, closing at just $2.56 per share. This dramatic fall in stock price has understandably raised eyebrows among investors, prompting many to seek legal guidance regarding potential securities fraud or related unlawful business practices that may have affected their investments.

Pomerantz LLP, with its extensive offices spread across New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is recognized as a leading firm in class action litigation, particularly in securities law. The firm was founded by Abraham L. Pomerantz, often heralded as the pioneer of the securities class action field. Over the past 85 years, Pomerantz has upheld its mission to advocate for the rights of investors, continuing to recover substantial awards on behalf of those impacted by securities fraud, breaches of fiduciary duty, and corporate misconduct.

For affected investors of SelectQuote, Pomerantz LLP is encouraging individuals to come forward and participate in the investigation. Interested parties can reach out to Danielle Peyton at the law firm directly via email at [email protected] or by phone at 646-581-9980, ext. 7980. Legal representation from trusted firms like Pomerantz is crucial for navigating the complexities of such allegations and understanding one’s rights and recourse options.

The ongoing investigation underscores the importance of vigilance in the corporate environment, particularly in sectors as sensitive as health insurance. Investors must remain informed about the practices of companies in which they hold shares, especially when allegations of malfeasance arise that can directly impact financial outcomes.

In the coming weeks, more information may develop as both the DOJ's case progresses and Pomerantz continues its investigation into the workings of SelectQuote. Investors and stakeholders are urged to stay tuned for updates and to monitor the progress of any legal developments that may stem from this situation.

For further information and updates about the investigation and its implications, investors are advised to keep an eye on communications from both Pomerantz LLP and relevant financial news outlets. In these challenging times, it is essential for investors to be proactive in understanding the potential impacts on their investments arising from corporate legal issues.